poly-N-acetyl glucosamine nanofibers

also known as sNAG

Developed for: decubitus ulcer
Investigated by: Marine Polymer Technologies, Inc. · University Hospital, Basel, Switzerland

today NCT02237287 · Ph 0

20112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 0	NCT02237287	Feb 2011 → Aug 2012	decubitus ulcer	University Hospital, Basel, Switzerland	Terminated	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	poly-N-acetyl glucosamine nanofibers	“thin interface of poly-N-acetyl glucosamine nanofibers (sNAG)” NCT02237287 ↗
Known as	sNAG	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02237287 ↗